ERISNSEEris Lifesciences LimitedLowNeutral
Announced Mon, 11 May · 11:38 IST

Eris Lifesciences Limited has informed the Exchange regarding Allotment of 24369 Shares.

Capital Market Events View source PDF

ERIS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.9%1-day move
₹1396.20
prior close
₹1390.60
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.1-0.2-0.1-0.3-2.9-4.1-2.2-1.7-4.5+6.7-2.4-2.2+4.2
Up moveDown movePending
AI summary

Eris Lifesciences has allotted 24,396 equity shares to employees who exercised options under the ESOP-2021 Scheme. The allotment was done across three grant years: 6,415 shares (2022 grant) at Rs. 557.24, 8,281 shares (2023 grant) at Rs. 510.32, and 9,673 shares (2024 grant) at Rs. 728.16 per share. The paid-up share capital increased from Rs. 13,85,42,887 to Rs. 13,85,67,256, reflecting the addition of 24,396 shares of Rs. 1 each. This is a routine ESOP exercise by employees.

Likely market impact

The allotment causes minimal dilution of approximately 0.018% to existing shareholders, which is negligible. This is a standard employee compensation event and has no material impact on the stock price or shareholder value.